189 related articles for article (PubMed ID: 33500573)
21. Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer.
Lv J; Zhu Y; Ji A; Zhang Q; Liao G
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32239176
[TBL] [Abstract][Full Text] [Related]
22. Mapping the Mutation Landscape of Colorectal Cancer.
Newsom KJ; Starostik P
Am J Med Sci; 2019 Nov; 358(5):313-314. PubMed ID: 31655711
[No Abstract] [Full Text] [Related]
23. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.
Luchini C; Bibeau F; Ligtenberg MJL; Singh N; Nottegar A; Bosse T; Miller R; Riaz N; Douillard JY; Andre F; Scarpa A
Ann Oncol; 2019 Aug; 30(8):1232-1243. PubMed ID: 31056702
[TBL] [Abstract][Full Text] [Related]
24. The clinical code-breakers.
Eisenstein M
Nature; 2018 Oct; 562(7726):291-293. PubMed ID: 30297737
[No Abstract] [Full Text] [Related]
25. Clinical cancer research: the past, present and the future.
DeVita VT; Eggermont AM; Hellman S; Kerr DJ
Nat Rev Clin Oncol; 2014 Nov; 11(11):663-9. PubMed ID: 25245981
[TBL] [Abstract][Full Text] [Related]
26. Molecular pathology in therapeutics: where are we now, and where are we going?
Harrison DJ; Faratian D
Curr Drug Targets; 2012 Nov; 13(12):1473-4. PubMed ID: 22974390
[No Abstract] [Full Text] [Related]
27. World's largest cancer charity lays out field's grand challenges.
Ledford H
Nature; 2015 Oct; 526(7573):301-2. PubMed ID: 26469017
[No Abstract] [Full Text] [Related]
28. Making precision oncology the standard of care.
The Lancet Oncology
Lancet Oncol; 2017 Jul; 18(7):835. PubMed ID: 28677559
[No Abstract] [Full Text] [Related]
29. Perspectives on geriatric oncology research presented at the 2018 European Society for Medical Oncology: Young international society of geriatric oncology report.
Baldini C; Mourey L; Liposits G
J Geriatr Oncol; 2019 Mar; 10(2):183-185. PubMed ID: 30595361
[No Abstract] [Full Text] [Related]
30. Editorial (Thematic Issue: Clinical Advances in Immuno-oncology - Progress Towards Selective Cure).
Liu X; Belani CP
Curr Mol Pharmacol; 2016; 9(3):182. PubMed ID: 26177639
[No Abstract] [Full Text] [Related]
31. CRISPR-cas9: a powerful tool towards precision medicine in cancer treatment.
Xing H; Meng LH
Acta Pharmacol Sin; 2020 May; 41(5):583-587. PubMed ID: 31792341
[TBL] [Abstract][Full Text] [Related]
32. Perspective on the application of pharmacogenomics in the treatment of cancer.
Wolf R
Pharmacogenomics; 2009 Apr; 10(4):527-9. PubMed ID: 19374511
[No Abstract] [Full Text] [Related]
33. [CD147: role and therapeutic targeting of a promising molecule in the treatment of cancers].
Landras A; Mourah S
Med Sci (Paris); 2020 Oct; 36 Hors série n° 1():47-49. PubMed ID: 33052094
[No Abstract] [Full Text] [Related]
34. [Players from the program "Investments for the Future": MAbImprove MabEx].
Larivière M; Pèlegrin A; Martineau P; Watier H
Med Sci (Paris); 2019 Dec; 35(12):1204-1205. PubMed ID: 31903941
[No Abstract] [Full Text] [Related]
35. Histology-agnostic drug development - considering issues beyond the tissue.
Pestana RC; Sen S; Hobbs BP; Hong DS
Nat Rev Clin Oncol; 2020 Sep; 17(9):555-568. PubMed ID: 32528101
[TBL] [Abstract][Full Text] [Related]
36. Using Somatic Mutations to Guide Treatment Decisions: Context Matters.
Horlings HM; Shah SP; Huntsman DG
JAMA Oncol; 2015 Jun; 1(3):275-6. PubMed ID: 26181166
[No Abstract] [Full Text] [Related]
37. Cancer therapy: an evolved approach.
Willyard C
Nature; 2016 Apr; 532(7598):166-8. PubMed ID: 27075079
[No Abstract] [Full Text] [Related]
38. Coming soon: a global grid for cancer research.
Bouchie A
Nat Biotechnol; 2004 Sep; 22(9):1071-3. PubMed ID: 15340462
[No Abstract] [Full Text] [Related]
39. Genome-wide CRISPR screens for the identification of therapeutic targets for cancer treatment.
Xue VW; Wong SCC; Cho WCS
Expert Opin Ther Targets; 2020 Nov; 24(11):1147-1158. PubMed ID: 32893711
[TBL] [Abstract][Full Text] [Related]
40. Global player in cancer research: IARC celebrates its 40th anniversary.
Steimle S
J Natl Cancer Inst; 2005 Oct; 97(19):1400-1. PubMed ID: 16204686
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
